Melinda Milliken
Adult Health · Paoli, PANPI 1013210764
Payments from drug & device makers
Across 161 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$890
- Sanofi$244
- Insmed, Inc.$235
- Mylan Specialty L.p.$201
- Intuitive Surgical$176
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,828100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 42 | $1,068 |
| GSK | 48 | $890 |
| Sanofi | 10 | $244 |
| Insmed, Inc. | 7 | $235 |
| Mylan Specialty L.p. | 10 | $201 |
| Intuitive Surgical | 1 | $176 |
| Regeneron Healthcare Solutions, Inc. | 6 | $174 |
| Philips North America LLC | 9 | $152 |
| Boehringer Ingelheim | 3 | $121 |
| Viatris Specialty LLC | 4 | $105 |
| Novartis | 3 | $74 |
| Amgen | 4 | $72 |
| Electromed, Inc. | 2 | $59 |
| AbbVie | 3 | $53 |
| Genentech USA, Inc. | 2 | $50 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Bayer | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| United Therapeutics Corporation | 1 | $19 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$176
- TEZSPIRE$125
- BREZTRI$120
How this compares
$3,828 in reported general payments places this provider in the 85th percentile of 899 adult health providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 196 | $180,130 |
| OfevNintedanib Esylate | 11 | $122,271 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $31,186 |
| Breo ElliptaFluticasone/Vilanterol | 59 | $27,101 |
| Spiriva RespimatTiotropium Bromide | 15 | $15,479 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $7,478 |
| EliquisApixaban | 12 | $7,202 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 33 | $5,696 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 38 | $5,353 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 156 | $5,179 |
| Ventolin HfaAlbuterol Sulfate | 48 | $2,876 |
| Azithromycin | 132 | $1,234 |
| Prednisone | 214 | $628 |
| CefuroximeCefuroxime Axetil | 49 | $541 |
| Montelukast Sodium | 38 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $890 | $207,231255 claims |
| Boehringer IngelheimOfev, Spiriva Respimat | $121 | $137,75026 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,068 | $38,66461 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Paoli
- Beth SandyPhiladelphia$924K
- Diane NewmanPhiladelphia$413K
- Jennifer MondilloSchwenksville$396K
- Elizabeth FaustDouglassville$356K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Lauren MassimoPhiladelphia$139K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.